Intraperitoneal injection of PFKFB3 inhibitor 3PO (35 mg/kg) inhibited the expressions of α-SMA, collagen 1, and collagen 3 in post-MI mice (Fig. 4a). This evidence concerns the gene ACTA1 and myocardial infarction.